116 related articles for article (PubMed ID: 8380918)
1. Short direct repeats flanking deletions, and duplicating insertions in p53 gene in human cancers.
Jego N; Thomas G; Hamelin R
Oncogene; 1993 Jan; 8(1):209-13. PubMed ID: 8380918
[TBL] [Abstract][Full Text] [Related]
2. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
3. Deletions and insertions in the p53 tumor suppressor gene in human cancers: confirmation of the DNA polymerase slippage/misalignment model.
Greenblatt MS; Grollman AP; Harris CC
Cancer Res; 1996 May; 56(9):2130-6. PubMed ID: 8616861
[TBL] [Abstract][Full Text] [Related]
4. Methylation and repeats in silent and nonsense mutations of p53.
Kouidou S; Malousi A; Maglaveras N
Mutat Res; 2006 Jul; 599(1-2):167-77. PubMed ID: 16620878
[TBL] [Abstract][Full Text] [Related]
5. Heterogenous point mutations in the BRCA1 breast cancer susceptibility gene occur in high frequency at the site of homonucleotide tracts, short repeats and methylatable CpG/CpNpG motifs.
Rodenhiser D; Chakraborty P; Andrews J; Ainsworth P; Mancini D; Lopes E; Singh S
Oncogene; 1996 Jun; 12(12):2623-9. PubMed ID: 8700521
[TBL] [Abstract][Full Text] [Related]
6. Translocation and gross deletion breakpoints in human inherited disease and cancer II: Potential involvement of repetitive sequence elements in secondary structure formation between DNA ends.
Chuzhanova N; Abeysinghe SS; Krawczak M; Cooper DN
Hum Mutat; 2003 Sep; 22(3):245-51. PubMed ID: 12938089
[TBL] [Abstract][Full Text] [Related]
7. Multiplex PCR (MPCR) Screening Can Detect Small Intragenic p53 Deletion and Insertion Mutations.
Runnebaum IB; Wang-Gohrke S
Methods Mol Med; 2001; 39():329-35. PubMed ID: 21340788
[TBL] [Abstract][Full Text] [Related]
8. Common chromosomal fragile site FRA16D mutation in cancer cells.
Finnis M; Dayan S; Hobson L; Chenevix-Trench G; Friend K; Ried K; Venter D; Woollatt E; Baker E; Richards RI
Hum Mol Genet; 2005 May; 14(10):1341-9. PubMed ID: 15814586
[TBL] [Abstract][Full Text] [Related]
9. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.
Sakamoto T; Nomura N; Mori H; Wake N
Gynecol Oncol; 1996 Nov; 63(2):173-9. PubMed ID: 8910623
[TBL] [Abstract][Full Text] [Related]
10. Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions.
Pollock PM; Pearson JV; Hayward NK
Genes Chromosomes Cancer; 1996 Feb; 15(2):77-88. PubMed ID: 8834170
[TBL] [Abstract][Full Text] [Related]
11. The rate of CpG mutation in Alu repetitive elements within the p53 tumor suppressor gene in the primate germline.
Yang AS; Gonzalgo ML; Zingg JM; Millar RP; Buckley JD; Jones PA
J Mol Biol; 1996 May; 258(2):240-50. PubMed ID: 8627622
[TBL] [Abstract][Full Text] [Related]
12. The 11 kb FGA deletion responsible for congenital afibrinogenaemia is mediated by a short direct repeat in the fibrinogen gene cluster.
Neerman-Arbez M; Antonarakis SE; Honsberger A; Morris MA
Eur J Hum Genet; 1999 Dec; 7(8):897-902. PubMed ID: 10602365
[TBL] [Abstract][Full Text] [Related]
13. Deletion and insertion in vivo somatic mutations in the hypoxanthine phosphoribosyltransferase (hprt) gene of human T-lymphocytes.
Burkhart-Schultz KJ; Jones IM
Environ Mol Mutagen; 1997; 30(4):371-84. PubMed ID: 9435878
[TBL] [Abstract][Full Text] [Related]
14. Large majority of single-nucleotide mutations along the dystrophin gene can be explained by more than one mechanism of mutagenesis.
Todorova A; Danieli GA
Hum Mutat; 1997; 9(6):537-47. PubMed ID: 9195228
[TBL] [Abstract][Full Text] [Related]
15. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR
Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268
[TBL] [Abstract][Full Text] [Related]
16. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
17. Accumulating mutations of p53 in colon tumor and hairy cell leukemia do not arise from methylation/deamination processes, but rather from nucleotide deletions and insertions.
Marcsek ZL; König EA
Biol Chem; 1998; 379(4-5):545-7. PubMed ID: 9628350
[TBL] [Abstract][Full Text] [Related]
18. Carcinogen-specific mutation pattern in the p53 tumour suppressor gene in UV radiation-induced basal cell carcinoma.
Weihrauch M; Bader M; Lehnert G; Wittekind C; Tannapfel A; Wrbitzky R
Int Arch Occup Environ Health; 2002 Apr; 75(4):272-6. PubMed ID: 11981662
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal relationship between the tumor suppressors p53 and BAX in primary colorectal cancers.
Simms LA; Radford-Smith G; Biden KG; Buttenshaw R; Cummings M; Jass JR; Young J; Meltzer SJ; Leggett BA
Oncogene; 1998 Oct; 17(15):2003-8. PubMed ID: 9788444
[TBL] [Abstract][Full Text] [Related]
20. [Theoretical analysis of mechanisms of occurrence of DNA deletions in prokaryotic genomes based on direct repeats].
Kel' AE; Kolchanov NA; Solov'ev VV
Mol Biol (Mosk); 1989; 23(1):184-92. PubMed ID: 2661992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
